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Abstract
N-oxidations of different nitrogen-containing heterocyclic 
molecules are often applied for synthetic transformations in 
chemistry. The industrial implementation of classical batch 
oxidation processes are limited due to safety concerns derived 
from metal ion catalyzed decompositions. These restrictions and 
other safety concern issues can be minimized or even avoided 
by applying glass made microreactor setups for this transfor-
mation. The N-oxidation of different pyridine derivative, qui-
noline and isoquinoline is studied using two popular oxidizing 
reagents. The further transformation of pyridine derivatives is 
studied through the Polonovski rearrangement in microreactor.
Keywords
microreactor technology · N-oxide · oxidation · Polonovski 
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Introduction
Microflow technology
In the recent years the importance of microreactors are con-
tinuously growing in R&D and industrial applications as well. 
This popularity originates from the unique properties of this 
technology such as: very precise temperature control, outstand-
ing mixing and heat exchange due to the high surface to volume 
ratio. With an extremely low active reactor volume, ‘safety 
concern’ chemicals and chemical processes can be handled in 
safe manner under inert conditions. Based on evidence gained 
from several examples, the scale-up of microreactors is also 
expected to be less problematic compared to batch processes, 
due to the reduced amount of critical scale-up parameters. [1]
In this paper, we describe our recent results on the N-oxida-
tion of different pyridine derivatives, quinoline and isoquino-
line with m-CPBA in DCM or aqueous H2O2 in acetic acid 
using microreactor technology.
N-oxide derivatives
The N-oxide type molecules can be found in several active 
pharmaceutical ingredients (such as: Chlordiazepoxide as seda-
tive, [2] Tirapazamine as anticancer, [3] Phenazopyridine, [4] 
Flupirtine, [5] Propirame [6] as analgestic, Phenyramidol mus-
cle relaxant [7]) (Figure 1), in addition N-oxides are typical 
metabolic intermediates in the human organism, so the syn-
thetic preparation of those N-oxides from tertiary amines has a 
high importance in drug development [8].
Since the aromatic substitution reactions of pyridine leads 
to meta-substituted derivatives even under harsh conditions, 
the N-oxide derivative has significance in synthetic transfor-
mations. In the substitution reaction of pyridine N-oxides the 
preferred products are ortho- and para-substituted derivatives, 
additionally the N-oxide can be easily reduced by PCl3, [9, 10] 
PPh3, [11] Raney Ni/H2 or Pd/C, [12] Fe/AcOH, [13] Zn/aq 
NH4Cl, [14] NaBH4/AlCl3, [15] NH4COOH-Pd/C, [16] TiCl3, 
[17] AlI3. [18]
Another very important application of the N-oxide inter-
mediate is the preparation of 2-hydroxypyridine derivatives, 
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Fig. 1. Biologically active 2-substituated pyridine and N-oxide derivatives
Fig. 2. Corning LF reactor with two plates (A) Nitrogen-containing com-
pound in solvent. (B) Oxidant. BPR: back pressure regulator
which can be synthesized with Polonovski rearrangement in the 
presence of TFAA or with Ac2O at high temperature. [19, 20] The 
2-hydroxypyridines can be further functionalized into different 
2-substituted pyridine derivatives. [21-26]
N-oxidants
Different N-oxidants are well known in the literature for het-
eroatom oxidation. In our studies, the reactions were carried 
out with m-CPBA in DCM or with aqueous H2O2 in acetic acid, 
so these compounds were described in detail regarding their 
safety aspect.
The m-chloroperoxybenzoic acid (m-CPBA) is an expensive 
reagent ($62/kg calculate to 1 ton pyridine). The material related 
safety concerns and issues are well-known in pharmaceutical 
pilot scale applications. [27, 28] The m-CPBA (commercial 
grade is 70-77%) is a shock sensitive and explosive compound 
but it can be stabilized by 3-chlorobenzoic acid. [29] Because 
of ~30% 3-chlorobenzoic acid the atom economy is low, so the 
application of the compound is not preferred environmentally.
The other important oxidant is H2O2. The heterocyclic com-
pounds do not react with a unique H2O2 therefore the utiliza-
tion of an acid is necessary, with which peracids are prepared 
in situ. The percarboxylic acids are very popular and easy to 
handle reactants, including the well-known and mostly applied 
peracetic acid. Hydrogen peroxide is an inexpensive (~$0.5/kg 
calculate to 1 ton pyridine) and easy to use reagent, but as a 
powerful oxidant, there are some limiting safety aspects for the 
large scale applications. Peroxide decomposes to oxygen and 
water while a large amount of heat is liberated which can lead 
to an increased rate of decomposition. The decomposition of 
H2O2 is continuous and goes on slow rate, but the decompo-
sition rate accelerates with increasing temperature. This rate 
increases about 2.2 times per 10°C temperature increase over 
the range 20 and 100°C. [30] The oxidizable materials (metals 
and their ions) catalyze exothermic decomposition of H2O2 and 
the effectiveness of decomposition decreases in the following 
order of metals: osmium, palladium, platinum, iridium, gold, sil-
ver, manganese, cobalt, copper, lead. [31] The addition of H2O2 
is incompatible with acetic anhydride, acetone, alcohols, carbox-
ylic acids, nitrogen-containing bases, organic compounds, since 
they catalyze its decomposition and it can cause explosion. [32] 
Pilot and industrial scale processes and the safe utilization of 
hydrogen peroxide are also well known. [27] N-oxidation with 
hydrogen peroxide in acetic acid is an eco-friendly process, 
generating water in the reaction. The used microreactor is made 
of borosilicate glass and it does not contain any metal, so H2O2 
does not decompose under the applied conditions.
In addition, other popular reagents for N-oxidations are: per-
phtalic acids (magnesium- monoperphtalate (MMPP)), [33] per-
formic acid, [34] pertrifuoricacetic acid, [35, 36] peroxymono-
sulfuric acid, [37] bromate, metal oxidants such as chromic acid 
and permanganate, [38] perphosphoric acid, [39] permaleinic 
acid [40, 41, 42] and urea-hydrogen peroxide (UHP). [43]
Results and Discussion
The applicability of a continuous N-oxidation is investi-
gated using pyridine with m-CPBA in DCM (Figure 2). The 
conversions are determined by HPLC. For the continuous pro-
cess a Corning LF type microreactor is used with two reactor 
plates (2x0.45ml volume) and a two line dosing with Encynova 
Novasync pump is applied (P1: pump 1 and P2: pump 2). The 
nitrogen-containing compounds in solvent are dosed through 
one of them, and the other line is used for the oxidant. The reac-
tion mixture is quenched with 10% water solution of sodium 
pyrosulfite. The effect of different reaction parameters under 
continuous conditions are investigated and summarized in 
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Table 1. The residence time and temperature are changed and 
the best result is achieved at 3 min residence time and 50 C, so 
all the other derivatives of pyridine are studied under this opti-
mized condition (Figure 3). Under batch conditions the reaction 
is carried out at room temperature and 3 min reaction time. The 
results of batch and continuous mode operation are compared but 
significant differences cannot be noticed in this case. This result 
can be explained by the rapid reaction therefore the advantage of 
using a microreactor in this case is not significant (Table 2).
Since the original aim of this research work is to develop an 
appropriate and environmentally friendly synthetic method for 
N-oxidation, next the effect of parameters on the N-oxidation 
of pyridine is studied with hydrogen peroxide in acetic acid as 
well (Table 3).
When the temperature is increased up to 150°C, 34% 
N-oxide is observed at increased residence time. The reaction 
is also studied between 100 and 150°C at increased residence 
time (30 min) and 5 eq H2O2 (Table 4). The best conversion is 
can be reached at 130°C, which is 91.5%.
 
 
Fig. 3. Reactions of pyridine derivatives, quinoline and isoquinoline with 
m-CPBA in DCM or with 27% water solution of H2O2 in acetic acid
temperature 
(°C)
residence time 
(min)
HPLC (relative area %)
2a 1a
1 50 0.25 89 11
2 50 0.5 94 6
3 50 1 95 5
4 50 2 98 2
5 50 3 100 0
6 100 0.25 94 6
7 100 0.5 94 6
8 100 1 94 6
Tab. 1. Results of pyridine with m-CPBA reactions in microreactor (2 bars) Tab. 3. Fast screening of pyridine with 27% water solution of H2O2 in 
acetic acid and microreactor (2 bars), 1.1 equivalent (eq) H2O2
Tab. 2. The comparison of results of pyridine derivatives, quinoline and isoquinoline with m-CPBA
temperature 
(°C)
residence time 
(min)
HPLC (relative area %)
2a 1a
1 50 1 0 100
2 50 5 0 100
3 50 10 0 100
4 100 10 12 88
5 150 10 34 66
Tab. 4. Temperature dependency of pyridine with 27% water solution of 
H2O2 in acetic acid in microreactor (2 bars) 5 eq H2O2, 30 min residence time
temperature 
(°C)
HPLC (relative area %)
2a 1a
1 100 49 51
2 110 33 67
3 120 12 88
4 130 9 91
5 140 13 87
6 150 33 67
Heterocycles
Pyridine derivatives HPLC (realtive area %, batch) RT HPLC (realtive area %, μreaktor) 50 °C, 2 bar
1 pyridine 96 (12a) 4 (11a) 100 (12a) 0 (11a)
2 2-methyl 95 (12b) 5 (11b) 95 (12b) 5 (11b)
3 2-ethyl 97 (12c) 3 (11c) 99,5 (12c) 0,5 (11c)
4 2-benzyl 92 (12d) 8 (11d) 92,5 (12d) 7,5 (11d)
5 3-methyl 96 (12e) 4 (11e) 97 (12e) 3 (11e)
6 2-bromo 90 (12f) 10 (11f) 92 (12f) 8 (11f)
7 3-bromo 80,5 (12g) 19,5 (11g) 84 (12g) 16 (11g)
8 2-cyano 54 (12h) 46 (11h) 56 (12h) 44 (11h)
9 4-cyano 47 (12i) 53 (11i) 60 (12i) 40 (11i)
10 quinoline 87 (25a) 13 (24a) 90 (25a) 10 (24a)
11 isoquinoline 85 (25b) 15 (24b) 92 (25b) 8 (24b)
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In the later experiments the temperature is fixed at 130°C. 
From the effect of residence time it can be seen that the con-
version decreases if the residence time is higher than 30 min, 
which can be due to the decomposition of the product (Table 5).
In the following experiments beside the fixed residence time 
and temperature, the effect of hydrogen peroxide excess is stud-
ied (Table 6). Complete conversion is reached at 7 eq of H2O2.
The optimized parameters (130°C, 7 eq H2O2, 30 min resi-
dence time; Table 5) are applied to study the N-oxidation of 
other N-heterocyclic compounds. Since the peracetic acid may 
explode at 110°C, [31] our batch reactions were carried out 
at 70°C based on the results of Ochiai E. [9] In the reaction 
of pyridine 34% conversion is reached in batch, contrary to 
the complete conversion in microreactor. The other nitrogen-
containing compounds are studied without optimization of the 
parameters, since our aim is to study and compare the different 
derivatives. The 2- and 3-substituted compounds give N-oxide 
products at low conversion in batch operation if H2O2 is pre-
sent. Especially the 2-bromopyridine give poor conversion in 
batch (2%), but in microreactor (15%), which can be further 
increased with reaction optimization. The quinoline and isoqui-
noline give similar results to those of the pyridine derivatives. 
In each cases, the results are significantly better in the microre-
actor than under batch conditions (Table 7).
Polonovski rearrangement
Pyridine N-oxide derivatives of Polonovski reaction are 
generally reacted with Ac2O for 2-8 hours at 130-160°C, so 
2-hydroxy or 2-acetate acid esters are produced. [20] Besides 
TFAA, other anhydrides can be used. [44, 45] The 2-hydroxy 
pyridine is produced from pyridine N-oxide at 130°C in batch 
and 33% conversion is can be achieved. This reaction is car-
ried out in microreactor at 170°C and 43% conversion is can be 
reached. The conversions are determined by 1H NMR. The reac-
tion is not optimized and only pyridine is studied as substance. 
Our aim is to investigate the Polonovski rearrangement under 
microreactor conditions, so a two steps reaction in microreac-
tor is assumed from pyridine derivatives to 2-hydroxy pyridine 
derivatives. Since our Encynova Novasync pump is limited up 
to two line dosing, therefore the two steps are implemented sep-
arately. In the case of an existing additional pump the two steps 
reaction could be performed in the microreactor (Figure 5).
Tab. 5. Residence time dependency of pyridine with 27% water solution of 
H2O2 in acetic acid (2 bars) 5 eq H2O2, at 130°C
residence time 
(min)
HPLC (relative area %)
2a 1a
1 18 15 85
2 24 12 88
3 30 8.5 91.5
4 36 16.5 83.5
Tab. 6. Residence time dependency of pyridine with 27% water solution 
of H2O2 in acetic acid in microreactor (2 bars) 30 min residence time at 130°C
H2O2 excess
HPLC (relative area %)
2a 1a
1 18 15 85
2 24 12 88
3 30 8.5 91.5
4 36 16.5 83.5
Tab. 7. The comparison of results of pyridine derivatives, quinoline and isoquinoline with 27% water solution of H2O2 in acetic acid
Heterocycles
Pyridine derivatives
HPLC (realtive area %,
batch) 70 °C
HPLC (relative area %,
μreaktor) 130°C, 2 bar
1 pyridine 34 (12a) 66 (11a) 100 (12a) 0 (11a)
2 2-methyl 16 (12b) 84 (11b) 62 (12b) 38 (11b)
3 2-ethyl 15 (12c) 85 (11c) 78 (12c) 22 (11c)
4 2-benzyl 19 (12d) 81 (11d) 66 (12d) 34 (11d)
5 3-methyl 28 (12e) 72 (11e) 80 (12e) 20 (11e)
6 2-bromo 2 (12f) 98 (11f) 15 (12f) 85 (11f)
7 3-bromo 9 (12g) 91 (11g) 65 (12g) 35 (11g)
8 2-cyano 41 (12h) 59 (11h) 79 (12h) 21 (11h)
9 4-cyano 30 (12i) 70 (11i) 92 (12i) 8 (11i)
10 quinoline 37 (25a) 64 (24a) 74 (25a) 26 (24a)
11 isoquinoline 26 (25b) 74 (24b) 64 (25b) 36 (24b)
 
 
 
 
 
 
Fig. 4. Polonovski reaction of pyridine N-oxide with Ac2O
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Conclusion
We present herein a beneficial continuous N-oxidation pro-
cess executed in a microreactor which is compared to the clas-
sical batch process. Applying the expensive m-CPBA reagent 
no significant differences are noticed between the continuous 
and the batch processes, except the increased process safety. 
The developed environmentally friendly synthetic method with 
aqueous H2O2 in acetic acid shows a significant improvement 
in a continuous mode compared to the classical batch process. 
Applicability of microreactor technology is also demonstrated 
on the Polonovski rearrangement. The further extension of the 
developed processes is in progress.
Experimental Section
All chemicals are purchased from Sigma-Aldrich except the 
27% water solution of H2O2 which is bought from Alfa Aesar. 
The pyridine is purchased from Reanal.
Reverse phase HPLC analyses are performed on an Agi-
lent 1100 equipment using a Waters Symmetry C18 column 
150x4.6mm, 5 μm using 10 mmol KH2PO4/H3PO4 buffer and 
acetonitrile (ACN) as eluent, the column temperature of 30°C, 
the flow rate of 1.0 mL/min. The standard gradient is used 10 to 
90% ACN over 5 min, followed by 90% ACN over 1 min and 
then 90 to 10% ACN over 0.1 min and 10% ACN for 3.9 min.
Reacttions in batch:
Pyridine N-oxide 65 μl 1a (63.28 mg, 0.8 mmol) is stirred 
in 0.5 ml dichloromethane at room temperature and 197.22 mg 
(0.88 mmol, 77%) m-CPBA is added. The reaction is stirred at 
3 min and checked by HPLC (255 nm, RT: 1a: 1.2, 2a: 1.7). 
The reaction mixture is added to 10% water solution of sodium 
pyrosulfite and washed with water (2x1 ml). Two phases are 
separated and organic phase is evaporated for analysis. All 
other analytical data of 2a are identical to the ones described 
in the literature. [46]
2-Methylpyridine N-oxide 81 μl 1b (74.50 mg, 0.8 mmol) 
is stirred in 0.5 ml dichloromethane at room temperature and 
197.22 mg (0.88 mmol, 77%) m-CPBA is added. The reaction 
is stirred at 3 min and checked by HPLC (258 nm, RT: 1b: 
1.3, 2b: 1.8). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2b are identical to the ones 
described in the literature. [47]
2-Ethylpyridine N-oxide 94 μl 1c (85.72 mg, 0.8 mmol) 
is stirred in 0.5 ml dichloromethane at room temperature and 
197.22 mg (0.88 mmol, 77%) m-CPBA is added. The reaction 
is stirred at 3 min and checked by HPLC (258 nm, RT: 1c: 
1.4, 2c: 3.4). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2c are identical to the ones 
described in the literature. [48]
2-Benzylpyridine N-oxide 131 μl 1d (135.38 mg, 0.8 mmol) 
is stirred in 0.5 ml dichloromethane at room temperature and 
197.22 mg (0.88 mmol, 77%) m-CPBA is added. The reaction 
is stirred at 3 min and checked by HPLC (262 nm, RT: 1d: 
3.6, 2d: 4.8). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2d are identical to the ones 
described in the literature. [49]
3-Methylpyridine N-oxide 79 μl 1e (74.50 mg, 0.8 mmol) 
is stirred in 0.5 ml dichloromethane at room temperature and 
197.22 mg (0.88 mmol, 77%) m-CPBA is added. The reaction 
is stirred at 3 min and checked by HPLC (258 nm, RT: 1e: 
1.3, 2e: 1.9). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2e are identical to the ones 
described in the literature. [49]
2-Bromopyridine N-oxide 76 μl 1f (126.40 mg, 0.8 mmol) 
is stirred in 0.5 ml dichloromethane at room temperature and 
197.22 mg (0.88 mmol, 77%) m-CPBA is added. The reaction 
is stirred at 3 min and checked by HPLC (262 nm, RT: 1f: 5.3, 
2f: 2.8). The reaction mixture is added to 10% water solution 
of sodium pyrosulfite and washed with water (2x1 ml). Two 
phases are separated and organic phase is evaporated for anal-
ysis. All other analytical data of 2f are identical to the ones 
described in the literature. [48]
3-Bromopyridine N-oxide 77 μl 1g (126.40 mg, 0.8 mmol) 
is stirred in 0.5 ml dichloromethane at room temperature and 
197.22 mg (0.88 mmol, 77%) m-CPBA is added. The reaction 
is stirred at 3 min and checked by HPLC (265 nm, RT: 1g: 
4.3, 2g: 3.0). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2g are identical to the ones 
described in the literature. [50]
2-Cyanopyridine N-oxide 72 μl 1h (83.29 mg, 0.8 mmol) 
is stirred in 0.5 ml dichloromethane at room temperature and 
 
 
 
 
 
Fig. 5. N-oxidation and Polonovski rearrangement reactions in Corning 
LF reactor with four plates (A) Nitrogen-containing compound in solvent. (B) 
Oxidant. (C) Ac2O. BPR: back pressure regulator
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197.22 mg (0.88 mmol, 77%) m-CPBA is added. The reaction 
is stirred at 3 min and checked by HPLC (222 nm, RT: 1h: 
4.3, 2h: 5.0). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2h are identical to the ones 
described in the literature. [51]
4-Cyanopyridine N-oxide 84.98 mg 1i (0.8 mmol) is stirred 
in 0.5 ml dichloromethane at room temperature and 197.22 mg 
(0.88 mmol, 77%) m-CPBA is added. The reaction is stirred 
at 3 min and checked by HPLC (220 nm, RT: 1i: 4.0, 2i: 1.9). 
The reaction mixture is added to 10% water solution of sodium 
pyrosulfite and washed with water (2x1 ml). Two phases are 
separated and organic phase is evaporated for analysis. All 
other analytical data of 2i are identical to the ones described in 
the literature. [48]
Quinoline N-oxide 97 μl 3a (103.33 mg, 0.8 mmol) is stirred 
in 0.5 ml dichloromethane at room temperature and 197.22 mg 
(0.88 mmol, 77%) m-CPBA is added. The reaction is stirred at 
3 min and checked by HPLC (230 nm, RT: 3a: 1.8, 4a: 3.8). 
The reaction mixture is added to 10% water solution of sodium 
pyrosulfite and washed with water (2x1 ml). Two phases are 
separated and organic phase is evaporated for analysis. All 
other analytical data of 4a are identical to the ones described in 
the literature. [48]
Isoquinoline N-oxide 97 μl 3b (103.33 mg, 0.8 mmol) is 
stirred in 0.5 ml dichloromethane at room temperature and 
197.22 mg (0.88 mmol, 77%) m-CPBA is added. The reaction 
is stirred at 3 min and checked by HPLC (215 nm, RT: 3b: 
1.8, 4b: 3.8). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 4b are identical to the ones 
described in the literature. [48]
Pyridine N-oxide 65 μl 1a (63.28 mg, 0.8 mmol) is stirred 
in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 5.6 mmol) 
27% water solution of H2O2 is added. The reaction is stirred at 
30 min and checked by HPLC (255 nm, RT: 1a: 1.2, 2a: 1.7). 
The reaction mixture is added to 10% water solution of sodium 
pyrosulfite and washed with water (2x1 ml). Two phases are 
separated and organic phase is evaporated for analysis. All 
other analytical data of 2a are identical to the ones described in 
the literature. [46]
2-Methylpyridine N-oxide 81 μl 1b (74.50 mg, 0.8 mmol) 
is stirred in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 
5.6 mmol) 27% water solution of H2O2 is added. The reaction 
is stirred at 30 min and checked by HPLC (258 nm, RT: 1b: 
1.3, 2b: 1.8). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2b are identical to the ones 
described in the literature. [47]
2-Ethylpyridine N-oxide 94 μl 1c (85.72 mg, 0.8 mmol) 
is stirred in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 
5.6 mmol) 27% water solution of H2O2 is added. The reaction 
is stirred at 30 min and checked by HPLC (258 nm, RT: 1c: 
1.4, 2c: 3.4). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2c are identical to the ones 
described in the literature. [47]
2-Benzylpyridine N-oxide 131 μl 1d (135.38 mg, 0.8 mmol) 
is stirred in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 
5.6 mmol) 27% water solution of H2O2 is added. The reaction 
is stirred at 30 min and checked by HPLC (262 nm, RT: 1d: 
3.6, 2d: 4.8). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2d are identical to the ones 
described in the literature. [48]
3-Methylpyridine N-oxide 79 μl 1e (74.50 mg, 0.8 mmol) 
is stirred in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 
5.6 mmol) 27% water solution of H2O2 is added. The reaction 
is stirred at 30 min and checked by HPLC (258 nm, RT: 1e: 
1.3, 2e: 1.9). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2e are identical to the ones 
described in the literature. [49]
2-Bromopyridine N-oxide 76 μl 1f (126.40 mg, 0.8 mmol) 
is stirred in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 
5.6 mmol) 27% water solution of H2O2 is added. The reaction 
is stirred at 30 min and checked by HPLC (262 nm, RT: 1f: 
5.3, 2f: 2.8). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2f are identical to the ones 
described in the literature. [48]
3-Bromopyridine N-oxide 77 μl 1g (126.40 mg, 0.8 mmol) 
is stirred in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 
5.6 mmol) 27% water solution of H2O2 is added. The reaction 
is stirred at 30 min and checked by HPLC (265 nm, RT: 1g: 
4.3, 2g: 3.0). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 2g are identical to the ones 
described in the literature. [50]
2-Cyanopyridine N-oxide 72 μl 1h (83.29 mg, 0.8 mmol) 
is stirred in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 
5.6 mmol) 27% water solution of H2O2 is added. The reaction 
is stirred at 30 min and checked by HPLC (222 nm, RT: 1h: 
4.3, 2h: 5.0). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
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Tab. 8. Flow rates with m-CPBA in Corning LF
analysis. All other analytical data of 2h are identical to the ones 
described in the literature. [51]
4-Cyanopyridine N-oxide 84.98 mg 1i (0.8 mmol) is stirred 
in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 5.6 mmol) 
27% water solution of H2O2 is added. The reaction is stirred at 
30 min and checked by HPLC (220 nm, RT: 1i: 4.0, 2i: 1.9). 
The reaction mixture is added to 10% water solution of sodium 
pyrosulfite and washed with water (2x1 ml). Two phases are 
separated and organic phase is evaporated for analysis. All 
other analytical data of 2i are identical to the ones described in 
the literature. [48]
Quinoline N-oxide 97 μl 3a (103.33 mg, 0.8 mmol) is stirred 
in 0.5 ml acetic acid at 70°C and 641µl (705.6 mg, 5.6 mmol) 
27% water solution of H2O2 is added. The reaction is stirred at 
30 min and checked by HPLC (230 nm, RT: 3a: 1.8, 4a: 3.8). 
The reaction mixture is added to 10% water solution of sodium 
pyrosulfite and washed with water (2x1 ml). Two phases are 
separated and organic phase is evaporated for analysis. All 
other analytical data of 4a are identical to the ones described in 
the literature. [48]
Isoquinoline N-oxide 97 μl 3b (103.33 mg, 0.8 mmol) is 
stirred in 0.5 ml acetic acid at 70°C and 641 µl (705.6 mg, 
5.6 mmol) 27% water solution of H2O2 is added. The reaction 
is stirred at 30 min and checked by HPLC (215 nm, RT: 3b: 
1.8, 4b: 3.8). The reaction mixture is added to 10% water solu-
tion of sodium pyrosulfite and washed with water (2x1 ml). 
Two phases are separated and organic phase is evaporated for 
analysis. All other analytical data of 4b are identical to the ones 
described in the literature. [48]
2-Hydroxypyridine 0.0125g 2a (0.13 mmol) is stirred in 0.5 
ml acetic anhydride at 130°C. The reaction is stirred at 30 min 
and 1 ml water is added. The reaction mixture is evaporated for 
analysis with heptane, which is checked by 1H NMR. All other 
analytical data of 5a are identical to the ones described in the 
literature. [52]
Reactions in the microreactor:
The reactions are studied in Corning LF reactor: The microre-
actor is fitted with a glass micro reactor (reactor volume = 0.45 
mL). Channel height: 3.34-3.66 mm, the smallest point in the 
microreactor: 0.4 mm in width. Reactant solutions are  introduced 
into the reactor through two lines of Encynova Novasync pump 
(Car-May LLC., USA) capable of delivering three solutions at 
flow rates between 1 μL/min and 120 mL/min. The system is 
maintained at max. 13 bar of back pressure in order to prevent 
the reactants and solvent system from boiling when temperatures 
above the atmospheric boiling point are employed. The solution 
of pyridine derivative (1a-1i, 3a, 3b) is pumped into the reactor 
from inlet A, the 27% water solution of H2O2 or m-CPBA in DCM 
is introduced from inlet B. After the system volume has passed 
through the reactor three times the reaction reached a steady state. 
The sample is then collected and analyzed offline by HPLC.
pyridine derivatives
temperature (°C) residence time (min)
flow rate (μL/min)
R= pyridine m-CPBA
1a H 50 0.25 1200 2400
1a H 50 0.50 600 1200
1a H 50 1.00 300 600
1a H 50 2.00 150 300
1a H 50 3.00 100 200
1a H 100 0.25 1200 2400
1a H 100 0.50 600 1200
1a H 100 1.00 300 600
1b 2-Me 50 3.00 71 229
1c 2-Et 50 3.00 100 200
1d 2-Bz 50 3.00 103 197
1e 3-Me 50 3.00 100 200
1f 2-Br 50 3.00 70 230
1g 3-Br 50 3.00 70 230
1h 2-CN 50 3.00 70 230
1i 4-CN 50 3.00 100 200
3a H 50 3.00 83 217
3b H 50 3.00 83 217
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Tab. 9. Flow rates with H2O2 in Corning LF
pyridine derivatives
temperature (°C) H2O2 excess residence time (min)
flow rate (μL/min)
R = pyridine m-CPBA
1a H 50 1.1 1 600 300
1a H 50 1.1 5 120 60
1a H 50 1.1 10 60 30
1a H 100 1.1 10 60 30
1a H 150 1.1 10 60 30
1a H 100 5 30 17 13
1a H 110 5 30 17 13
1a H 120 5 30 17 13
1a H 130 5 30 17 13
1a H 140 5 30 17 13
1a H 150 5 30 17 13
1a H 130 5 18 28 22
1a H 130 5 24 21 16
1a H 130 5 36 14 11
1a H 130 4 30 17 13
1a H 130 6 30 16 14
1a H 130 7 30 15 15
1b 2-Me 130 7 30 16 15
1c 2-Et 130 7 30 17 13
1d 2-Bz 130 7 30 17 13
1e 3-Me 130 7 30 15 15
1f 2-Br 130 7 30 15 15
1g 3-Br 130 7 30 14 16
1h 2-CN 130 7 30 15 15
1i 4-CN 130 7 30 15 15
3a H 130 7 30 15 15
3b H 130 7 30 15 15
pyridine derivatives residence time (min)
P1 pump P2 pump
1a-i; 3a-b
(mL)
DCM (mL)
77%            m-
CPBA (g)
DCM (mL)
pyridine (1a)
30 1 21 1.5 20
60 1 21 1.5 20
120 1 21 1.5 20
180 1 21 1.5 20
15 1 21 1.5 20
2-methypiridine (1b) 180 1 16.60 1.5 20
2-etilpiridin (1c) 180 1 14.00 1.5 20
2-benzylpyridine (1d) 180 1 9.80 1.5 20
3-methylpyridine (1e) 180 1 17.00 1.5 20
2-bromopyridine (1f) 180 1 17.55 1.5 20
3-bromopyridine (1g) 180 1 17.35 1.5 20
2-cyanopyridine (1h) 180 1 17.15 1.5 20
4-cyanopyridine (1i) 180 1a 15.65 1.5 20
quinoline (3a) 180 1 13.65 1.5 20
isoquinoline (3b) 180 1 13.60 1.5 20
Tab. 10. Preparation of reaction mixtures in Corning LF
a 4-cyanopyridine (1i) 1 g is dissolved in DCM
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Tab. 11. Preparation of reaction mixture in Corning LF
pyridine derivatives
H2O2 excess 
(eq.)
residence time 
(min)
P1 pump P2 pump
1a-i; 3a-b (mL) AcOH (mL) 27% H2O2 (mL)  H2O (mL)
pyridine (1a)
1.1 1 2 15 10 17.50
1.1 5 2 15 10 17.50
1.1 10 2 15 10 17.50
1.1 10 2 15 10 17.50
1.1 10 2 15 10 17.50
5 30 1 8.30 20 0
5 30 1 8.30 20 0
5 30 1 8.30 20 0
5 30 1 8.30 20 0
5 30 1 8.30 20 0
5 30 1 8.30 20 0
5 18 1 8.00 20 0
5 24 1 8.30 20 0
5 36 1 8.00 20 0
4 30 1 6.40 20 0
6 30 1 8.70 20 0
7 30 1 8.90 20 0
2-methypiridine (1b) 7 30 1 6.95 20 0
2-etilpiridin (1c) 7 30 1 7.90 20 0
2-benzylpyridine (1d) 7 30 1 5.40 20 0
3-methylpyridine (1e) 7 30 1 7.15 20 0
2-bromopyridine (1f) 7 30 1 7.25 20 0
3-bromopyridine (1g) 7 30 1 6.30 20 0
2-cyanopyridine (1h) 7 30 1 7.25 20 0
4-cyanopyridine (1i) 7 30 1a 6.55 20 0
quinoline (3a) 7 30 1 5.65 20 0
isoquinoline (3b) 7 30 1 5.60 20 0
a 4-cyanopyridine (1i) 1 g is dissolved in AcOH
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